These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2553792)

  • 1. Nuclear enzymes, fragile sites, and cancer.
    Yunis JJ; Hoffman WR
    J Gerontol; 1989 Nov; 44(6):37-44. PubMed ID: 2553792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fragile sites are targets of diverse mutagens and carcinogens.
    Yunis JJ; Soreng AL; Bowe AE
    Oncogene; 1987 Mar; 1(1):59-69. PubMed ID: 3438083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of common chromosomal fragile site genes, WWOX/FRA16D and FHIT/FRA3B is downregulated by exposure to environmental carcinogens, UV, and BPDE but not by IR.
    Thavathiru E; Ludes-Meyers JH; MacLeod MC; Aldaz CM
    Mol Carcinog; 2005 Nov; 44(3):174-82. PubMed ID: 16187332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nickel (II) enhances benzo[a]pyrene diol epoxide-induced mutagenesis through inhibition of nucleotide excision repair in human cells: a possible mechanism for nickel (II)-induced carcinogenesis.
    Hu W; Feng Z; Tang MS
    Carcinogenesis; 2004 Mar; 25(3):455-62. PubMed ID: 14604891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fragile sites on human chromosomes and cancer-specific chromosomal rearrangements].
    Hori T
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):667-76. PubMed ID: 3963838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzo[a]pyrene diol epoxide and bleomycin sensitivity and susceptibility to cancer of upper aerodigestive tract.
    Wu X; Gu J; Hong WK; Lee JJ; Amos CI; Jiang H; Winn RJ; Fu KK; Cooper J; Spitz MR
    J Natl Cancer Inst; 1998 Sep; 90(18):1393-9. PubMed ID: 9747870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzo[a]pyrene diol epoxide-induced 9p21 aberrations associated with genetic predisposition to bladder cancer.
    Hazra A; Grossman HB; Zhu Y; Luo S; Spitz MR; Wu X
    Genes Chromosomes Cancer; 2004 Dec; 41(4):330-8. PubMed ID: 15390186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fragile sites, cancer chromosome breakpoints, and oncogenes all cluster in light G bands.
    Hecht F
    Cancer Genet Cytogenet; 1988 Mar; 31(1):17-24. PubMed ID: 3162186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic alterations in cancer as a result of breakage at fragile sites.
    Popescu NC
    Cancer Lett; 2003 Mar; 192(1):1-17. PubMed ID: 12637148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further characterization of benzo[a]pyrene diol-epoxide (BPDE)-induced comet assay effects.
    Bausinger J; Schütz P; Piberger AL; Speit G
    Mutagenesis; 2016 Mar; 31(2):161-9. PubMed ID: 26346062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Removal of benzo(a)pyrene diol epoxide (BPDE)-DNA adducts as a measure of DNA repair capacity in lymphoblastoid cell lines from sisters discordant for breast cancer.
    Motykiewicz G; Faraglia B; Wang LW; Terry MB; Senie RT; Santella RM
    Environ Mol Mutagen; 2002; 40(2):93-100. PubMed ID: 12203401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common fragile sites as targets for chromosome rearrangements.
    Arlt MF; Durkin SG; Ragland RL; Glover TW
    DNA Repair (Amst); 2006 Sep; 5(9-10):1126-35. PubMed ID: 16807141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fragile sites, mutagens and genomic rearrangements in cancer.
    Yunis JJ
    Basic Life Sci; 1988; 43():11-21. PubMed ID: 3284518
    [No Abstract]   [Full Text] [Related]  

  • 14. Benzo[a]pyrene diol epoxide-induced 3p21.3 aberrations and genetic predisposition to lung cancer.
    Wu X; Zhao Y; Honn SE; Tomlinson GE; Minna JD; Hong WK; Spitz MR
    Cancer Res; 1998 Apr; 58(8):1605-8. PubMed ID: 9563468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzo(a)pyrene diol epoxide-induced chromosomal aberrations and risk of lung cancer.
    Wei Q; Gu J; Cheng L; Bondy ML; Jiang H; Hong WK; Spitz MR
    Cancer Res; 1996 Sep; 56(17):3975-9. PubMed ID: 8752166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent genomic rearrangements are not at the fragile sites on chromosomes 3 and 5 in human renal cell carcinomas.
    Kovacs G; Brusa P
    Hum Genet; 1988 Sep; 80(1):99-101. PubMed ID: 3417313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common fragile sites associated with the breakpoints of chromosomal aberrations in hematologic neoplasms.
    Gümüş G; Sunguroğlu A; Tükün A; Sayin DB; Bökesoy I
    Cancer Genet Cytogenet; 2002 Mar; 133(2):168-71. PubMed ID: 11943347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of stably transfected human glutathione S-transferase P1-1 protects against DNA damage by benzo[a]pyrene diol-epoxide in human T47D cells.
    Fields WR; Morrow CS; Doss AJ; Sundberg K; Jernström B; Townsend AJ
    Mol Pharmacol; 1998 Aug; 54(2):298-304. PubMed ID: 9687571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early whole-genome transcriptional response induced by benzo[a]pyrene diol epoxide in a normal human cell line.
    Lu X; Shao J; Li H; Yu Y
    Genomics; 2009 Apr; 93(4):332-42. PubMed ID: 19150397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benzo(a)pyrene diol epoxide-induced chromosome 9p21 aberrations are associated with increased risk of bladder cancer.
    Gu J; Horikawa Y; Chen M; Dinney CP; Wu X
    Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2445-50. PubMed ID: 18768515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.